Search - tctmd.com

Displaying 101 - 120 of 196

Sort: Relevancy | Date

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Conference News ESC 2021

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

Caitlin E. Cox

August 31, 2021

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 2

Todd Neale

August 08, 2021

News Conference News HRS 2021

J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’

Shelley Wood

July 28, 2021

News Daily News

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Yael L. Maxwell

July 01, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Caitlin E. Cox

June 14, 2021

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Todd Neale

May 17, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Caitlin E. Cox

April 05, 2021

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

Advertisement

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Diabetes Progression in Statin-Treated Patients: VA Data

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

‘Quadpill’ Beats Monotherapy at BP Lowering: QUARTET

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

COVID-19: TCTMD’s Daily Dispatch for August Week 2

J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’

ISAR-REACT 5: Subanalysis of PCI Patients Confirms Prasugrel Superiority

Statins Not Linked to Dementia or Memory Changes: ASPREE

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Pneumonia in HF Patients Is Common, Lethal, and Preventable

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content